Working… Menu

Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02228772
Recruitment Status : Completed
First Posted : August 29, 2014
Last Update Posted : November 26, 2019
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Philip C. Amrein, M.D., Massachusetts General Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2016
Actual Study Completion Date : November 2019